Mangalam Drugs And Organics Limited (MANGALAM) — Announcement | 16 May 2026

StockFin.ai

Try Free

📢 Key Event
Company discloses loan default exceeding 30 days to exchanges

💡 Investor Takeaway
Shareholders face potential reputational damage and possible regulatory scrutiny from the default disclosure.

Mangalam Drugs and Organics Limited disclosed a loan default exceeding 30 days on obligations to Bank of Baroda and Bank of Maharashtra, with overdue amounts of ₹951.97 lakhs and ₹606.08 lakhs respectively as of May 15, 2026. The company is arranging payment and has formally notified the exchanges under SEBI's disclosure requirements.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MANGALAM ✨ Ask AI About This

About Mangalam Drugs And Organics Limited (MANGALAM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

View full MANGALAM stock details →

📡 Get AI alerts when MANGALAM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANGALAM — Free

💡 Ask AI about this filing

"How does this affect MANGALAM margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More MANGALAM filings

See all MANGALAM filings →

🔥 Also filed on 16 May 2026

DELHIVERY Delhivery Limited Financial Results LATENTVIEW Latent View Analytics Limited Financial Results NEULANDLAB Neuland Laboratories Limited Financial Results LATENTVIEW Latent View Analytics Limited Financial Results UTTAMSUGAR Uttam Sugar Mills Limited Financial Results MANGLMCEM Mangalam Cement Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when MANGALAM files new disclosures

Track MANGALAM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANGALAM — Free

Free account · 2 AI queries/day